An Evolving Clinical Trial Narrative: 7 Industry Leaders Weigh In On Patient Engagement & Recruitment

After more than 275 years since what is believed to have been the first clinical trial in 1747, the clinical study landscape has undergone significant transformations, thanks to technological advancements and data utilization. In today's world, clinical trial engagement, and recruitment innovations aim to address major challenges, such as lack of awareness and trust, excessive burden, isolated experiences, manual operations, and growing complexity.

Nonetheless, the effectiveness of technology and digital solutions hinges on the ecosystem and experiences they create for those driving their usage or development. Despite the progress made, specific barriers persist, as only 46% of studies initiated in the past five years have met their enrollment targets, necessitating 1.4 million participants actively enrolling in phase 3 studies.

Citeline Connect recently sought insights from leaders representing different facets of the clinical trial ecosystem. Collaborative reflection on this year's activities aims to garner learnings that will ensure successful trial outcomes and, more importantly, pave the way for a brighter future, where people worldwide can lead longer, healthier, and more hopeful lives.